pfizer-opensource/nf-crispr-primer-design is a bioinformatics pipeline that designs primers
for sequencing CRISPR-edited target sites. The pipeline takes CRISPR guide sequences as
input, finds their location in a reference genome, and then designs primers to amplify
the edited region. In addition to outputing target-specific primers, the pipeline can
also generate primers with NGS adapter sequences added on. This pipeline is a companion
to the pfizer-opensource/nf-gene-editing-ngs pipeline, and produces an amplicons.yaml
file
that is compatible with that gene editing NGS analysis pipeline.
Note
If you are new to Nextflow and nf-core, please refer to this page on how to set-up Nextflow.
The only required input file is a tab-delimited text file with guide identifiers and guide sequences. The input data should look like this:
guides.txt
:
guide_id guide_seq
HPRT-ctrl AATTATGGGGATTACTAGGA
Each row represents a CRISPR guide, and a primer pair will be designed for that guide.
You will also need to tell the pipeline which reference genome to use for the primer design and a prefix string to use for naming the output files.
Now, you can run the pipeline using:
nextflow run pfizer-opensource/nf-crispr-primer-design \
-profile <docker/singularity/.../institute> \
--input guides.txt \
--genome GRCh38 \
--prefix my_guides \
--outdir <OUTDIR>
Warning
Please provide pipeline parameters via the CLI or Nextflow -params-file
option. Custom config files including those provided by the -c
Nextflow option can be used to provide any configuration except for parameters; see docs.
pfizer-opensource/nf-crispr-primer-design was originally written by Jason Arroyo.
If you would like to contribute to this pipeline, please see the contributing guidelines.
An extensive list of references for the tools used by the pipeline can be found in the CITATIONS.md
file.
This pipeline uses code and infrastructure developed and maintained by the nf-core community, reused here under the MIT license.
The nf-core framework for community-curated bioinformatics pipelines.
Philip Ewels, Alexander Peltzer, Sven Fillinger, Harshil Patel, Johannes Alneberg, Andreas Wilm, Maxime Ulysse Garcia, Paolo Di Tommaso & Sven Nahnsen.
Nat Biotechnol. 2020 Feb 13. doi: 10.1038/s41587-020-0439-x.